Related Experiment Videos
[Extraparathyroid hypercalcemias. Physiopathological and therapeutic aspects]
P Houillier1, A Blanchard, M Paillard
1Service de Physiologie, Hôpital Broussais, Paris.
Annales De Medecine Interne
|January 1, 1997
Summary
Hypercalcemia results from increased calcium input, decreased kidney filtration, or increased tubular reabsorption. Treatment focuses on fluid volume and inhibiting bone calcium release.
Area of Science:
- Nephrology
- Endocrinology
- Calcium Metabolism
Context:
- Hypercalcemia, an elevation in plasma calcium, arises from specific physiological events.
- Understanding these mechanisms is crucial for diagnosing and managing hypercalcemia.
Purpose:
- To elucidate the distinct pathophysiological pathways of parathyroid hormone-related and parathyroid hormone-independent hypercalcemia.
- To outline the key determinants and consequences of elevated plasma calcium concentrations.
Summary:
- Hypercalcemia stems from increased calcium input, reduced glomerular filtration rate, or enhanced tubular reabsorption.
- Parathyroid hormone-related hypercalcemia primarily involves increased tubular reabsorption, while parathyroid hormone-independent forms, like cancer-related hypercalcemia, are driven by increased calcium input.
- Progressive hypercalcemia can lead to sodium loss, volume depletion, reduced GFR, and further calcium reabsorption, creating a detrimental cycle.
Impact:
- Provides a clear framework for understanding hypercalcemia's origins and progression.
- Highlights the importance of addressing extracellular fluid volume and bone resorption in treatment strategies.
- Aids clinicians in differentiating hypercalcemia subtypes for targeted therapeutic interventions.